22/09/2020
Innovation and Exploitation Advisory Panel (IEAP)
The RELENT Innovation and Exploitation Advisory Panel (IEAP) will ensure the results of RELENT are communicated and disseminated as swiftly as possible while foreground with innovation/exploitation opportunities will remain protected. The IEAP will provide support the scientists regarding intellectual property rights (IPR) management and business opportunities.
Members of the IEAP
- Prof. Renate Kain, M.D., Ph.D.
Medical University of Vienna - Dr. Paul Lyons, University of Cambridge
- Prof. Karl-Heinz Wiesmüller, EMC microcollections GmbH
- Dr. Brigitte Onteniente
- Dr. Erik Toonen, Hycult biotechnology bv
- Prof. Peter Nilsson, KTH - Royal Institute of Technology
